4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-23-012016
CFO & COO sold 9,856 shares at $4.67 ($46,028)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAY MICHAEL CFO & COO | 2023-02-22 | Sale | −9,856 | $4.67 | $46,028 | 27,610 | D |
| Open-market sales · 9,856 sh · avg $4.67 · $46,028 | |||||||
Loading xslF345X03/doc4.xml…